Sio Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Sio Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-530,175	Closed	-$6.14M	–	93
2019 Q1	$7.36M	Buy	530,175 +360,918	+213%	+$4.13M	1.99%	18
2018 Q4	$1.85M	Buy	+169,257	New	+$1.78M	0.67%	50
2018 Q1	–	Sell	-83,428	Closed	-$496K	–	53
2017 Q4	$496K	Buy	83,428 +58,246	+231%	+$400K	0.28%	42
2017 Q3	$187K	Sell	25,182 -219,668	-90%	-$1.83M	0.1%	52
2017 Q2	$2.29M	Sell	244,850 -49,300	-17%	-$362K	1.09%	38
2017 Q1	$2.14M	Sell	294,150 -31,100	-10%	-$224K	1.2%	26
2016 Q4	$2.41M	Sell	325,250 -288,640	-47%	-$2.08M	1.4%	32
2016 Q3	$3.71M	Sell	613,890 -28,938	-5%	-$137K	2.56%	12
2016 Q2	$2.89M	Buy	+642,828	New	+$2.41M	1.47%	22

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sio Capital Management's CCXI Position: Q2 2019 in Review

Sio Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2019, closing a stake of 530,175 shares — an estimated $6.14M sold.

Sio Capital Management first reported a position in CCXI in Q2 2016 and held it in 9 quarters. The position peaked at $7.36M in Q1 2019. 117 funds tracked by Wall St. Rank hold CCXI as of Q2 2019.

Sio Capital Management reported no remaining ChemoCentryx, Inc. position as of Q2 2019 after selling out during the quarter.
Sio Capital Management sold 530,175 ChemoCentryx, Inc. shares in Q2 2019, an estimated $6.14M.
Sio Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2016 and held it in 9 quarters.
Sio Capital Management's ChemoCentryx, Inc. position peaked at $7.36M in Q1 2019.
117 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2019.

Based on Sio Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.